| In-house lobbyists who participated in the lobbying activity: |
Derek Badger
Ilias Iliopoulos
|
|
Senior Public Office Holders who were lobbied in this activity:
|
Brenda Bailey,
Minister of Jobs, Economic Development and Innovation
Minister's Office,
Jobs, Economic Development and Innovation
Fazil Mihlar,
Deputy Minister
Jobs, Economic Development and Innovation
Paul Pawlowski,
Assistant Deputy Minister
Major Investments Office,
Jobs, Economic Development and Innovation
|
| |
Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Discussions with BC Government officials, organizations and elected representatives to obtain pubic funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.
|
- Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade
|
Discussions with BC government officials/organizations and elected representative to obtains public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.
|
- Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.
|
- Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Science and Technology
|
|
| |
|
Senior officer who filed this Lobbying Activity Report:
|
Kiersten Combs
|
| |
|
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
|